Although the factors controlling the secretion of the nenropeptide somatostatin have been extensively studied, little is known about the mechanisms that control somatostatin biosynthesis. Somatostatin secretion is regulated by numerous agents that increase intracellular levels of CAMP. We sought to determine whether CAMP also regulates somatostatin mRNA accnmnlation. We found that forskolin elicited an increase in somatostatin secretion and mRNA levels in primary cultures of rat diencephalic cells. Another secretagogne, KCl, was as effective as forskolin in causing somatostatin secretion but had no effect on mRNA accumulation. Somatostatin expression in fibroblast cells transfected with the somatostatin gene was also regulated by forskolin. These results demonstrate that somatostatin mRNA accumulation can be regulated through a CAMP-dependent pathway, that this pathway is operative in heterologons cells transfected with the somatostatin gene, and that stimulation of somatostatin secretion and mRNA accumulation can be nnconpled from one another.
The neuropeptide somatostatin is widely distributed throughout the nervous system. In addition to its well-known role as a hypophysiotropic hormone, somatostatin also appears to serve as a neurotransmitter or neuromodulator. Somatostatin release from neurons is, in turn, regulated by a number of classical neurotransmitters and neuropeptides (for reviews, see Arimura and Fishback, 198 1; Reichlin, 1983) .
Although the effects of neuroregulators on the release of somatostatin have been extensively studied, little is known about the molecular mechanisms that control the synthesis of this peptide or the extent to which synthesis is regulated by factors that influence secretion. Secretion of somatostatin is increased by numerous agents that stimulate adenyl cyclase activity, including vasoactive intestinal peptide (Robbins and Landon, 1985; Tapia-Arancibia and Reichlin, 1984) , glucagon (Shimatsu et al., 1982) and epinephrine (Chihara et al., 1979) . Recent evidence showing that CAMP regulates the expression of several eukaryotic genes has prompted us to ask whether CAMP similarly regulates somatostatin biosynthesis and, if so, whether the regulation of somatostatin biosynthesis is obligatorily coupled to secretion of the peptide. As an index of biosynthesis, we have followed the accumulation of somatostatin mRNA. In this paper we examine the effects of forskolin, a postreceptor activator of adenyl cyclase, on somatostatin production in primary cultures of rat diencephalic cells. We demonstrate that forskolin stimulates both the secretion of immunoreactive somatostatin and the accumulation of somatostatin mRNA. To determine whether the increase in somatostatin mRNA was invariably linked to the stimulation of release, we examined the response of the cultured neurons to high concentrations of K+, a CAMP-independent secretagogue. We found that K+, in contrast to forskolin, did not increase the levels of somatostatin mRNA. As an initial step in characterizing the mechanism of CAMP induction, we transfected the rat somatostatin gene into mouse fibroblast cells, which normally do not contain somatostatin. We found that the transfected fibroblast cells produced immunoreactive somatostatin, and that the levels of both somatostatin protein and of somatostatin mRNA were increased by forskolin. We conclude that CAMP regulates somatostatin biosynthesis and secretion but that secretion of the peptide is not invariably coupled to biosynthesis.
Materials and Methods

Preparation of diencephalic cultures
Primary monolayer cultures were prepared by dissociating fetal (embryonic day 17) rat diencephalon as described previously (Delfs et al.. 1980) . Plating of 5 x lo6 cells per 25 cm2 tissue culture flask was carried out in Minimal Essential Medium (Grand Island Bioloaical Co.) containing 10% Nu Serum (Collaborative Research Inc.) &d Bacitracin. Seven-day-old cultures were washed with Earle's balanced salt solution (Grand Island Biochemical Co.) and then treated for l-4 hr with medium containing either 1 PM forskolin (PL Biochemicals) or 30 mM KCl.
Determination of somatostatin secretion
For measurement of somatostatin secretion, the media were decanted from the treated cultures, acidified in 1 N acetic acid, lyophilized, and assayed for immunoreactive somatostatin (Pate1 and Reichlin, 1978) . The antiserum used in this radioimmunoassay recognizes the midportion of the somatostatin tetradecapeptide and detects somatostatin-14, somatostatin-28, and amino-terminally extended fragments of somatostatin-28.
Extraction of RNA from primary cultures
For measurement of somatostatin mRNA, cells were washed with cold Ca-free Hank's medium and were resuspended in 10 mM Tris (pH 7.0)/ 0.15 M NaC1/2 mM MgCl, containing 10 units of RNAsin (Promega Biotech). The suspension was treated with 0.5% NP-40 for 5 min at o"C, and the nuclear pellet and cytoplasm were separated by centrifugation (6500 x g). The supematant, containing cytoplasmic RNA, was added to an equal volume of STE buffer (0.1 M NaCVlO mM Tris (pH 7.0)/l mM EDTA) and extracted with phenol : chloroform. RNA in the aqueous phase was precipitated in ethanol. The RNA pellet was dissolved in 2.5 M NH,Cl and reprecipitated in ethanol. RNA yields were Vol. 6, No. 4, Apr. 1986 quantitated by absorption at 260 and 280 nM. A,,, : A,,, ratios were consistently 1.95-2.0, indicating that the samples were essentially free of contaminating protein.
Construction of the somatostatin antisense RNA hybridization probe Levels of somatostatin mRNA were quantitated by Northern blot hybridization using an antisense somatostatin RNA probe. The antisense RNA probe was constructed by inserting a fragment of the rat preprosomatostatin cDNA (Goodman et al., 1983) into the expression vector pSp65 (Promega Biotech) ( Fig. 1 ). To perform this construction, pSp65 was cleaved with the restriction enzymes Xba I and Barn HI. The linearized plasmid was purified by electrophoresis on a 0.7% agarose gel. A DNA fragment containing the complete pre-prosomatostatin coding sequence in addition to a portion of the 3' untranslated region was prepared by cleaving the somatostatin cDNA with the restriction enzymes Xba I and Sau 3A and isolating the 450 base-pair coding sequence by agarose gel electrophoresis. The vector and somatostatin-coding sequence fragment were ligated using T4-DNA ligase. This construction places the somatostatin coding sequence in reverse orientation with respect to the bacteriophage Sp6 promotor and allows the generation of antisense RNA molecules. The ligated vector was introduced into competent E. coli MC 106 1 by calcium shock (Dagert and Ehrlich, 1979) and was amplified using standard techniques (Maniatis et al., 1982) . The orientation of the somatostatin coding region within the vector was confirmed by restriction endonuclease mapping. Labeled antisense somatostatin RNA probes were prepared according to the method recommended by the manufacturer (Promega Biotech).
Northern blot hybridization assays
Five micrograms of each RNA sample were electrophoresed on a 1% agarose gel containing formaldehyde and were transferred to nitrocellulose. To confirm that each lane of the gel contained equal amounts of RNA, 5 fig aliquots were also electrophoresed in parallel on nondenaturing gels stained with ethidium bromide. The ribosomal signals were quantitated by densitometry using an LKB scanner. The signal obtained using these procedures is a linear function of the amount of RNA applied (Zingg et al., 1984) . Blots were prehybridized for 3 hr at 65°C in 6 x SSC (1 x SSC = 0.15 M NaCl, 0.0 15 M Na citrate), 5 x Denhardt's (1 x Denhardt's = 0.02% polyvinylpyrrolidone, Ficoll, and BSA), 50% formamide, 100 fig/ml salmon sperm DNA, and were hybridized for 48 hr under the same conditions with 4 x lo6 cpm/ml of the antisense RNA probe. Blots were washed 3 x at 65°C in 2 x SSC/O. 1% SDS, followed by three washes at the same temperature in 0.2 x SSC/@l% SDS. Autoradiograms were developed after exposure to x-ray film for 4 hr at -80°C using an intensifying screen. The intensity of hybridizing signals was quantitated by densitometry.
Gene constructions and transfections NIH 3T3 fibroblast cells were transfected with the plasmid DSpSal (Fig.  2 ) which contains the rat somatostatin gene (Montminy et al., 1984) extending from 750 base pairs upstream from the promoter to 3 kilobases downstream from the coding sequence.
Cells were transfected using the calcium phosphate coprecipitation technique (Graham and Van der Eb, 1973) . For 10' 3T3 cells, 10-20 pg of D3pSal and 1 pg of the selectable marker pSV2neo were used. Cotransfection with the plasmid pSV2neo allows the selection of stably transformed cells that have integrated the neomycin-resistance gene into their genome (Southern and Berg, 1982) . These cells can be selected by their ability to grow on the neomycin analog G418. Transfected cells were grown in Dulbecco's Minimal Essential Medium, containing 10% calf serum, penicillin-streptomycin, and 400 &ml G4 18. After 2 weeks of selection, G4 18-resistant clones were subcultured and analyzed for their ability to produce immunoreactive somatostatin. Clones that produced somatostatin were maintained in culture for further analysis.
Southern blot analysis of transfected cell lines
Stable integration of the somatostatin gene into fibroblast cells was demonstrated by Southern blot analysis. Genomic DNA was prepared from 3T3 cells transfected with the somatostatin gene using the method of Blin and Stafford (1976) . Cells from confluent 100 mm dishes were harvested and treated with NP40 as described for mRNA extractions. Nuclear pellets were resuspended in 200 ~1 STE supplemented with 0.1% SDS, then treated with proteinase K (200 j&ml) for 3 hr. The viscous solutions were extracted 3 x with phenol : chloroform and were subsequently dialyzed extensively against TE (10 mM Tris, pH 8/l mM EDTA). Five micrograms of genomic DNA from each sample were digested with the restriction enzyme Eco Rl, and the samples were electrophoresed on a 0.7% agarose gel alongside a Hind III-digested lambda-DNA size marker. The gel was denatured, blotted onto nitrocellulose, and prehybridized as described previously (Montminy et al., 1984) . The blot was hybridized with 10' cpm/ml 32P-labeled somatostatin antisense RNA for 15 hr. After hybridization, the blot was washed 3 x at 50°C in 2 x SSC/O. 1% SDS followed by three washes in 0.2 x SSC/O. 1% SDS. Hybridizing bands were detected by autoradiography.
Results
Somatostatin secretion was measured in primary cultures of embryonic day 17 rat diencephalic cells in the basal state and after administration of forskolin. These cultures contain approximately 3% somatostatin-producing cells (Delfs et al., 1980) . Forskolin (1 KM) caused a twofold increase in somatostatin secretion over a period of 4 hr (Fig. 3) consistent with previous studies (Robbins et al., 1982) . To determine whether the increase in somatostatin secretion caused by forskolin was associated with an increase in somatostatin mRNA accumulation, we performed Northern blot hybridization assays. Preliminary studies showed that the level of sensitivity obtained using conventional nick-translated cDNA hybridization probes was not sufficient to allow us to detect somatostatin mRNA in the pri- Fig. 2 ). DNA samples were digested to completion with the restriction enzyme, EcoRl. All three lanes show two major hybridizing EcoRl bands of 1 and 7.2 kilobases. These sizes coincide with the fragments predicted from the structure of D3pSal. Lanes 2-4 contain genomic DNA from the transfected clones D3pSa15, D3pSa17, and D3pSa18, respectively.
FCEF FCFFC skolin treatment was accompanied by a three-to fourfold increase in somatostatin mRNA (Fig. 3) . To determine whether the increase in somatostatin mRNA was a consequence of somatostatin secretion per se, we treated the diencephalic cells with 30 mM KCl. This level of KC1 was as effective as forskolin. in stimulating somatostatin secretion but had no effect on somatostatin mRNA accumulation (Fig. 3) . To assure that KC1 did not have a toxic effect on the diencephalic cells, somatostatin mRNA levels were assayed in cells treated with KC1 and forskolin. The somatostatin mRNA levels in these cells were no different from those in cells treated with forskolin alone, indicating that 30 mM KC1 does not have a toxic effect on mRNA accumulation. As a first step toward characterizing the mechanism by which CAMP induces somatostatin biosynthesis, we introduced the cloned rat somatostatin gene into heterologous cells. The host cells for these studies, NIH-3T3 fibroblasts, do not normally produce somatostatin. We used the CaPO, technique (Graham and Van der Eb, 1973) to cotransfect 3T3 cells with the somatostatin gene and the selectable marker pSV2neo.
Three stably transfected cell lines were assayed by Southern blot analysis for integration of the somatostatin gene (Fig. 4) . The fragments detected in EcoR 1 -digested cellular DNA indicated that between 20-30 copies of the somatostatin gene had integrated in a head-to-tail fashion and were not rearranged. Somatostatin mRNA expressed by these cells was the same size Figure 5 . Time course of forskolin-induced somatostatin mRNA accumulation in transfected 3T3 cells. This autoradiogram of a Northern blot depicts the amount of hybridizable somatostatin mRNA in either control (c), 0.1% ethanol-(E), or lo+ M forskolin-Q treated cells. Individual culture dishes containing 10' cells were harvested after 1, 2, and 4 hr of treatment. The corresponding cytoplasmic RNAs were prepared and analyzed for somatostatin mRNA accumulation. Ethanol treatment was performed because forskolin powder was initially dissolved in 100% ethanol prior to dilution into medium. Final ethanol concentration in forskolin-treated samples was also 0.1%. In this and other experiments, the effect of ethanol on somatostatin mRNA accumulation was negligible. This experiment was performed on a single transfected clone, D3pSa15. However, the two other transfected 3T3 lines, D3pSa17 and D3pSal8, showed similar somatostatin mRNA induction in response to forskolin.
as that found in normal somatostatin-producing tissues (Goodman et al., 1983) . Gel-filtration chromatography of immunoreactive somatostatin elaborated by the transfected cells revealed primarily higher molecular weight forms with negligible amounts of biologically active somatostatin-14 or -28 peptides (data not shown). These cells apparently do not possess the processing enzymes necessary for the production of either of these bioactive forms.
Unlike neuronal cells, the transfected 3T3 cells did not appear to store somatostatin efficiently. More than 90% of the immunoreactive somatostatin produced by the transfected cells was found in the media. Therefore, we have used both the cellular mRNA levels and the media levels of immunoreactive somatostatin as indices of somatostatin biosynthesis.
To determine whether CAMP could modulate expression of the somatostatin gene in a heterologous cell, we analyzed somatostatin mRNA levels in the 3T3 cells before and after treatment with forskolin. In each of the three transfected cell lines, somatostatin mRNA levels increased within 1 hr and became maximal (8 to lo-fold increase) within 4 hr of forskolin treatment (Fig. 5) . Somatostatin mRNA was not detectable in nontransfected 3T3 cells exposed to 1 PM forskolin.
After exposure to 1 /IM forskolin, the 3T3 cell lines transfected with the somatostatin gene also increased their production of immunoreactive somatostatin 2-3 x (Table 1 ). This increase in immunoreactive somatostatin was additionally seen after treatment of the cells with cholera toxin (1 pg/ml) and 1 mM dibutyryl CAMP, agents also known to increase intracellular levels of CAMP (data not shown). These studies indicate that CAMP increases expression of the transfected somatostatin gene at the level of mRNA accumulation and that the increased mRNA levels are associated with an increased synthesis of the peptide.
Discussion
The purpose of our studies was to determine whether somatostatin biosynthesis was modulated by factors that regulate somatostatin secretion. We chose to examine the effects of forskolin, an agent that elevates intracellular levels of CAMP through a postreceptor mechanism. Cyclic AMP-dependent mechanisms appear to represent a common pathway for agents that have been shown to influence somatostatin secretion (Reichlin, 1983) .
Forskolin caused an increase in both somatostatin secretion and mRNA levels in cultured diencephalic cells. These results suggested that somatostatin mRNA accumulation might be coupled to secretion of the peptide. We considered two alternative hypotheses to explain these observations. The first, a cellular depletion model, proposed that somatostatin biosynthesis is regulated by intracellular levels of the neuropeptide. In this model, somatostatin secretion would be expected to stimulate somatostatin mRNA accumulation by depleting peptide stores. The second model proposed that CAMP could stimulate somatostatin mRNA accumulation and peptide secretion independently.
We tested these hypotheses by treating the cultured cells with KC1 at levels that were as effective as CAMP in stimulating somatostatin secretion. KC1 did not increase somatostatin mRNA levels. These results demonstrated that secretion of somatostatin could be uncoupled from mRNA accumulation.
To determine whether the CAMP-dependent regulation of somatostatin production occurred only in normal somatostatinproducing cells, we transfected mouse fibroblast cells with a somatostatin gene construction that contained 750 base pairs of the 5' flanking region. Three G4 18-resistant cell lines that expressed the foreign somatostatin gene were identified. Each of these cell lines responded to forskolin by increasing their production of somatostatin mRNA and immunoreactive protein. These studies indicate that all of the sequences necessary for regulation by CAMP are contained within the 4.2 kilobase gene fragment and that the increase in somatostatin mRNA, at least in fibroblast cells, is associated with an actual increase in biosynthesis of the peptide.
Our data for CAMP induction of somatostatin mRNA accumulation do not discriminate between increased transcriptional rate, increased precursor splicing, or decreased degradation of the mature somatostatin mRNA. However, we have recently observed that a fusion gene containing the somatostatin promoter ligated to the bacterial marker chloramphenicol acetyl transferase (CAT), is also regulated by CAMP when transfected into the neuroendocrine cell line PC 12 (M. R. Montminy et al., unpublished observations) . In contrast, a fusion gene containing the SV40 promoter linked to the CAT gene is not activated by CAMP. These studies suggest that the CAMP responsiveness that we observed affects the somatostatin gene specifically, and that the sequences essential for induction are found in the 5' flanking region of the gene.
Other CAMP-inducible eukaryotic genes have recently been identified, including that coding for prolactin (Murdoch et al., 1982) and proenkephalin (Eiden et al., 1984) . A 620 base-pair DNA fragment upstream from the rat phosphoenolpyruvate carboxykinase gene has been identified that confers CAMP inducibility when fused to the promoter of the Herpes thymidine kinase gene (Wynshaw-Boris et al., 1984) . This latter effect appears to be tissue-specific, as the induction is seen only in transfected hepatoma cells. The CAMP regulatory region that we have identified in the rat somatostatin gene, on the other hand, is functional in 3T3 cells, which do not normally produce somatostatin.
In summary, our studies suggest that somatostatin secretion and somatostatin mRNA accumulation are independently regulated by CAMP. Our findings further suggest that some of the factors that increase activity of somatostatinergic neurons may also be able to influence somatostatin biosynthesis. Neurotransmitters such as dopamine that increase adenyl cyclase activity may differ in this regard from other factors that stimulate somatostatin release without elevating intracellular levels of CAMP.
